Literature DB >> 22639180

How to investigate and treat: headache and hyperprolactinemia.

Gennaro Bussone1, Susanna Usai, Franca Moschiano.   

Abstract

Hyperprolactinemia is a condition characterised by an increase of prolactin blood levels (more than 100-200 ng/ml). It is the most common endocrine disorder of the hypothalamic-pituitary axis. The clinical characteristics of the headache-hyperprolactinemia-hypophyseal-adenoma association are discussed, the various diagnostic and treatment possibilities are explored and the etiology of the headache is considered in the light of several pathogenetic possibilities. We present two cases. (1) A 35-year-old woman suffering from chronic tension-type headache interspersed with occasional episodes of migraine without aura (as defined by the International Headache Society criteria). She had also suffered menstrual cycle alterations since the age of 16. At the age of 30 she developed amenorrhea with hyperprolactinemia. Computed tomography (CT) and magnetic resonance imaging (MRI) scans revealed a median-left intrasellar mass. Treatment with cabergoline resulted in complete resolution of both types of headache and the menstrual cycle and prolactin levels returned to normal. The therapy also reduced the volume of the tumour. (2) The second case relates to a 47-year-old man who had been suffering from tension-type headaches for almost 3 months. The patient had never previously suffered from headaches. CT and MRI scans showed a large sellar and suprasellar lesion with raised serum prolactin levels. Treatment with cabergoline had significantly reduced the prolactin levels and had also improved the patient's headaches. High-resolution CT, with and without contrast, or MRI is necessary to visualise microprolactinomas (and other sellar lesions) and confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639180     DOI: 10.1007/s11916-012-0267-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  39 in total

1.  Headache associated with pituitary adenomas.

Authors:  T Abe; K Matsumoto; J Kuwazawa; I Toyoda; K Sasaki
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

2.  SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks.

Authors:  H Massiou; J M Launay; C Levy; M El Amrani; B Emperauger; M G Bousser
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

3.  Cabergoline in the long-term therapy of hyperprolactinemic disorders.

Authors:  C Ferrari; A Paracchi; A M Mattei; S de Vincentiis; A D'Alberton; P Crosignani
Journal:  Acta Endocrinol (Copenh)       Date:  1992-06

4.  A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline.

Authors:  Kiyoshi Negoro; Motoharu Kawai; Yukiko Tada; Jun-Ichi Ogasawara; Shungo Misumi; Mitsunori Morimatsu
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

5.  The clinical characteristics of headache in patients with pituitary tumours.

Authors:  M J Levy; M S Matharu; K Meeran; M Powell; P J Goadsby
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

6.  Long-acting bromocriptine for the acute treatment of large macroprolactinomas.

Authors:  A Zarate; C Moran; R Miranda; M Loyo; M Medina; M E Fonseca
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

Review 7.  Hyperprolactinemia: etiology, diagnosis, and management.

Authors:  Peak Mann Mah; Jonathan Webster
Journal:  Semin Reprod Med       Date:  2002-11       Impact factor: 1.303

8.  Pituitary volume and headache: size is not everything.

Authors:  Miles J Levy; H Rolf Jäger; Michael Powell; Manjit S Matharu; Karim Meeran; Peter J Goadsby
Journal:  Arch Neurol       Date:  2004-05

9.  Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.

Authors:  Erdal Eren; Şenay Yapıcı; Esra Deniz Papatya Çakır; Latife Aytekin Ceylan; Halil Sağlam; Ömer Tarım
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-06-08

10.  Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine.

Authors:  Jasna Zidverc-Trajkovic; Svetlana Vujovic; Ana Sundic; Aleksandra Radojicic; Nadezda Sternic
Journal:  J Headache Pain       Date:  2009-09-11       Impact factor: 7.277

View more
  4 in total

1.  Evidence for hyperprolactinemia in migraineurs: a systematic review and meta-analysis.

Authors:  Ali Noori-Zadeh; Morvarid Karamkhani; Ali Seidkhani-Nahal; Afra Khosravi; Shahram Darabi
Journal:  Neurol Sci       Date:  2019-08-23       Impact factor: 3.307

Review 2.  Clinical Presentation and Management of Headache in Pituitary Tumors.

Authors:  Himanshu Suri; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

3.  Is pituitary MRI screening necessary in cluster headache?

Authors:  Lou Grangeon; Emer O'Connor; Daisuke Danno; Thanh Mai Pham Ngoc; Sanjay Cheema; Erling Tronvik; Indran Davagnanam; Manjit Matharu
Journal:  Cephalalgia       Date:  2021-01-06       Impact factor: 6.292

4.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.